EUVIMEDEUVIMED entdecken
Crossref

A Synergistic Sonosensitive Pyroptosis Nanoactivator for Efficient Lung Adenocarcinoma Therapy

Yanqiu Duan, Xinran Song iD, Wenting Ye, Ying Zhu, Meng Li iD, Lili Liu iD, Hao Fu iD, Lei Wang, Yu Chen iD, Meiqi Chang iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.71729 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yanqiu Duan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Science and Technology Innovation Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Med…. Hauptthemen laut MEDLINE: Pyroptosis, Lung Neoplasms, Adenocarcinoma of Lung. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Shanghai Science and Technology Committee Rising-Star Program, Shanghai Young Talent Program of Eastern Talent Plan, Wenzhou Basic Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The critical challenge of apoptosis resistance severely constrains the efficacy of conventional cancer therapies. To address this issue, this study turns to pyroptosis, a lytic cell death pathway, and develops a novel therapeutic strategy by repurposing triptolide (TPL), a natural compound from traditional Chinese medicine (TCM), as a potent pyroptosis inducer. We rationally co‐load TPL with the sonosensitizer rose bengal (RB) into a customized covalent organic framework (COF) to construct a synergistic nanoplatform (CRT). The “old drug, new trick” paradigm is potentiated by a nanomaterial‐mediated synergistic mechanism: US‐triggered reactive oxygen species (ROS) generation from RB orchestrates a dual action, simultaneously inducing direct mitochondrial damage and initiating the controlled release of TPL. This dual action creates a feed‐forward loop that drives the progressive amplification of cytotoxic signals from both agents, culminating in the cooperative and robust activation of caspase‐3/GSDME‐mediated pyroptosis. Consequently, this CRT platform effectively circumvents apoptotic resistance, demonstrating tumor‐selective accumulation, potent antitumor efficacy in lung cancer models, and a highly favorable biosafety profile. This work establishes a precise and noninvasive nanomedicine paradigm, highlighting how advanced biomaterial design can unlock the synergistic potential of repurposed drugs for next‐generation cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisLung NeoplasmsAdenocarcinoma of LungHumansAnimalsReactive Oxygen SpeciesEpoxy CompoundsDiterpenesMiceCell Line, TumorRose BengalApoptosisMice, NudeNanoparticlesPhenanthrenes

Stichwörter der Autor:innen

covalent organic frameworknanomedicinenanozymepyroptosissonodynamic therapysynergistic therapy

Substanzen

Reactive Oxygen SpeciesEpoxy CompoundsDiterpenestriptolideRose BengalPhenanthrenes

Autor:innen und Institutionen

  • Science and Technology Innovation Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen Universi…
  • School of Nursing, Gansu University of Chinese Medicine, Lanzhou, China.
  • Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, China.
  • Department of Ultrasound, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Xinran Song, Meng Li, Lili Liu, Hao Fu, Yu Chen, Meiqi Chang

Förderung

  • Shanghai Science and Technology Committee Rising-Star Program
  • Shanghai Young Talent Program of Eastern Talent Plan
  • Wenzhou Basic Scientific Research Project
  • China National Postdoctoral Program for Innovative Talents
  • Yat-sen Postdoctoral Grow-up Program and Guangdong Basic and Applied Basic Research Foundation

Zitieren

APA

Duan, Y., Song, X., Ye, W., Zhu, Y., Li, M., Liu, L., Fu, H., Wang, L., Chen, Y., & Chang, M. (2026). A Synergistic Sonosensitive Pyroptosis Nanoactivator for Efficient Lung Adenocarcinoma Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71729

Vancouver

Duan Y, Song X, Ye W, Zhu Y, Li M, Liu L, et al. A Synergistic Sonosensitive Pyroptosis Nanoactivator for Efficient Lung Adenocarcinoma Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71729

BibTeX
@article{Duan2026,
  author = {Duan, Yanqiu and Song, Xinran and Ye, Wenting and Zhu, Ying and Li, Meng and Liu, Lili and Fu, Hao and Wang, Lei and Chen, Yu and Chang, Meiqi},
  title = {A Synergistic Sonosensitive Pyroptosis Nanoactivator for Efficient Lung Adenocarcinoma Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71729}
}
Kostenlos starten →